Janssen Pharmaceuticals, Inc.


Recent News About Janssen Pharmaceuticals, Inc. View More

Houston men sue in Philly as J&J faces more claims from Invokana users who say they were at higher risk for amputations

By Nicholas Malfitano | Dec 18, 2018

PHILADELPHIA – More lawsuits are alleging that Johnson & Johnson’s diabetes medication, Invokana, gave them an increased risk of suffering amputations – and that the company failed to warn them of that same risk.

Three more plaintiffs allege Invokana makers failed to warn them of increased risk for amputations

By Nicholas Malfitano | Dec 10, 2018

PHILADELPHIA – A trio of new lawsuits joins others recently filed taking aim at Johnson & Johnson’s Invokana medication for Type 2 diabetes, claiming the company failed to warn its users that the medicine put them at increased risk for amputations they suffered as a result of taking the drug.

'Verdilization': It's how a baby lawsuit is made

By The Pennsylvania Record | Nov 5, 2018

All it takes is one maturing into a headline-grabbing, multimillion-dollar verdict to spawn thousands more like it.

The Record Network